{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:41:41Z","timestamp":1759408901338,"version":"build-2065373602"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["24K12479"],"award-info":[{"award-number":["24K12479"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"apan Agency for Medical Research and Development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02414-6","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:21:33Z","timestamp":1759407693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IGFBP2 alteration contributes to prostate cancer progression by modulating prostate stroma activation"],"prefix":"10.1186","volume":"23","author":[{"given":"Mingguo","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soki","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketoshi","family":"Nara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Numakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nanjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Habuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"2414_CR1","first-page":"43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43\u201366.","journal-title":"CA Cancer J Clin"},{"key":"2414_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrurol.2014.42","volume":"11","author":"K Ito","year":"2014","unstructured":"Ito K. Prostate cancer in Asian men. Nat Rev Urol. 2014;11:197\u2013212.","journal-title":"Nat Rev Urol"},{"key":"2414_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/carcin\/bgp043","volume":"30","author":"I Kogan-Sakin","year":"2009","unstructured":"Kogan-Sakin I, Cohen M, Paland N, Madar S, Solomon H, Molchadsky A, Brosh R, Buganim Y, Goldfinger N, Klocker H, et al. Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1. Carcinogenesis. 2009;30:698\u2013705.","journal-title":"Carcinogenesis"},{"key":"2414_CR4","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1158\/0008-5472.CAN-06-3946","volume":"67","author":"M Ao","year":"2007","unstructured":"Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res. 2007;67:4244\u201353.","journal-title":"Cancer Res"},{"key":"2414_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrc1387","volume":"4","author":"MN Pollak","year":"2004","unstructured":"Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer. 2004;4:505\u201318.","journal-title":"Nat Rev Cancer"},{"key":"2414_CR6","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1054\/bjoc.2000.1462","volume":"83","author":"AG Renehan","year":"2000","unstructured":"Renehan AG, Jones J, Potten CS, Shalet SM, O\u2019Dwyer ST. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Br J Cancer. 2000;83:1344\u201350.","journal-title":"Br J Cancer"},{"key":"2414_CR7","first-page":"4228","volume":"59","author":"GN Fuller","year":"1999","unstructured":"Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WK, Zhang W. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res. 1999;59:4228\u201332.","journal-title":"Cancer Res"},{"key":"2414_CR8","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/bjc.2014.435","volume":"111","author":"S Han","year":"2014","unstructured":"Han S, Li Z, Master LM, Master ZW, Wu A. Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to Temozolomide in glioma cells via the integrin beta1-ERK pathway. Br J Cancer. 2014;111:1400\u20139.","journal-title":"Br J Cancer"},{"key":"2414_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-4-7","volume":"4","author":"EJ Lee","year":"2005","unstructured":"Lee EJ, Mircean C, Shmulevich I, Wang H, Liu J, Niemisto A, Kavanagh JJ, Lee JH, Zhang W. Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer. 2005;4: 7.","journal-title":"Mol Cancer"},{"key":"2414_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1756-8722-6-72","volume":"6","author":"X Chen","year":"2013","unstructured":"Chen X, Zheng J, Zou Y, Song C, Hu X, Zhang CC. IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells. J Hematol Oncol. 2013;6:72.","journal-title":"J Hematol Oncol"},{"key":"2414_CR11","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1038\/s41388-021-01865-8","volume":"40","author":"YH Wu","year":"2021","unstructured":"Wu YH, Huang YF, Chang TH, Chen CC, Wu PY, Huang SC, Chou CY. COL11A1 activates cancer-associated fibroblasts by modulating TGF-beta3 through the NF-kappaB\/IGFBP2 axis in ovarian cancer cells. Oncogene. 2021;40:4503\u201319.","journal-title":"Oncogene"},{"key":"2414_CR12","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/mc.23746","volume":"63","author":"G Wang","year":"2024","unstructured":"Wang G, Zhuang T, Zhen F, Zhang C, Wang Q, Miao X, Qi N, Yao R. IGF2BP2 inhibits invasion and migration of clear cell renal cell carcinoma via targeting Netrin-4 in an m(6)a-dependent manner. Mol Carcinog. 2024;63:1572\u201387.","journal-title":"Mol Carcinog"},{"key":"2414_CR13","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.18632\/oncotarget.27355","volume":"10","author":"Z Tang","year":"2019","unstructured":"Tang Z, Gillatt D, Rowe E, Koupparis A, Holly JMP, Perks CM. IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells. Oncotarget. 2019;10:7043\u201357.","journal-title":"Oncotarget"},{"key":"2414_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg1840","volume":"9","author":"JRW Conway","year":"2023","unstructured":"Conway JRW, Dinc DD, Follain G, Paavolainen O, Kaivola J, Bostrom P, Hartiala P, Peuhu E, Ivaska J. IGFBP2 secretion by mammary adipocytes limits breast cancer invasion. Sci Adv. 2023;9: eadg1840.","journal-title":"Sci Adv"},{"key":"2414_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/1940-6207.CAPR-12-0250","volume":"6","author":"ML Neuhouser","year":"2013","unstructured":"Neuhouser ML, Platz EA, Till C, Tangen CM, Goodman PJ, Kristal A, Parnes HL, Tao Y, Figg WD, Lucia MS, et al. Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial. Cancer Prev Res Phila. 2013;6:91\u20139.","journal-title":"Cancer Prev Res Phila"},{"key":"2414_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/ERC-21-0107","volume":"29","author":"CH Chau","year":"2022","unstructured":"Chau CH, Till C, Price DK, Goodman PJ, Neuhouser ML, Pollak MN, Thompson IM, Figg WD. Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial. Endocr Relat Cancer. 2022;29:99\u2013109.","journal-title":"Endocr Relat Cancer"},{"key":"2414_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.42","volume":"5","author":"M Huang","year":"2016","unstructured":"Huang M, Koizumi A, Narita S, Inoue T, Tsuchiya N, Nakanishi H, Numakura K, Tsuruta H, Saito M, Satoh S, et al. Diet-induced alteration of fatty acid synthase in prostate cancer progression. Oncogenesis. 2016;5: e195.","journal-title":"Oncogenesis"},{"key":"2414_CR18","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1073\/pnas.0609139104","volume":"104","author":"R Mehrian-Shai","year":"2007","unstructured":"Mehrian-Shai R, Chen CD, Shi T, Horvath S, Nelson SF, Reichardt JK, Sawyers CL. Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K\/Akt pathway activation in glioblastoma and prostate cancer. Proc Natl Acad Sci U S A. 2007;104:5563\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2414_CR19","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/ijc.24202","volume":"124","author":"MA Rowlands","year":"2009","unstructured":"Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer. 2009;124:2416\u201329.","journal-title":"Int J Cancer"},{"key":"2414_CR20","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1073\/pnas.1120375109","volume":"109","author":"KM Holmes","year":"2012","unstructured":"Holmes KM, Annala M, Chua CY, Dunlap SM, Liu Y, Hugen N, Moore LM, Cogdell D, Hu L, Nykter M, et al. Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-kappaB network. Proc Natl Acad Sci U S A. 2012;109:3475\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2414_CR21","doi-asserted-by":"crossref","unstructured":"Ramos C, Walterskirchen N, Knobl V, Zotter C, Muller C, Gerakopoulos V, Rauch A, Falk L, Sachet M, D\u2019Angelo E, et al. Colorectal cancer peritoneal metastasis is promoted by tissue-specific fibroblasts that can arise in response to various local disorders. Cancer Lett. 2025:217686.","DOI":"10.1016\/j.canlet.2025.217686"},{"key":"2414_CR22","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","volume":"186","author":"J Massague","year":"2023","unstructured":"Massague J, Sheppard D. TGF-beta signaling in health and disease. Cell. 2023;186:4007\u201337.","journal-title":"Cell"},{"key":"2414_CR23","doi-asserted-by":"publisher","first-page":"R187","DOI":"10.1530\/ERC-12-0085","volume":"19","author":"DA Barron","year":"2012","unstructured":"Barron DA, Rowley DR. The reactive stroma microenvironment and prostate cancer progression. Endocr Relat Cancer. 2012;19:R187\u2013204.","journal-title":"Endocr Relat Cancer"},{"key":"2414_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/bjc.2016.255","volume":"115","author":"C Bellomo","year":"2016","unstructured":"Bellomo C, Caja L, Moustakas A. Transforming growth factor beta as regulator of cancer stemness and metastasis. Br J Cancer. 2016;115:761\u20139.","journal-title":"Br J Cancer"},{"key":"2414_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/cac2.12137","volume":"41","author":"M Huang","year":"2021","unstructured":"Huang M, Koizumi A, Nara T, Numakura K, Satoh S, Nanjo H, Habuchi T. Macrophage inhibitory cytokine-1 induced by a high-fat diet promotes prostate cancer progression by stimulating tumor-promoting cytokine production from tumor stromal cells. Cancer Commun (Lond). 2021;41:389\u2013403.","journal-title":"Cancer Commun (Lond)"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02414-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:21:35Z","timestamp":1759407695000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02414-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2414"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02414-6","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of the Akita University School of Medicine approved all the experiments, which were performed after obtaining individual written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All Authors agreed to the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors hereby certify and declare that all authors participated in the study and that all authors have seen and approved the manuscript. I also certify that the contents of this manuscript are not now under consideration for publication elsewhere, and the contents will not be copyrighted, submitted, or published elsewhere while acceptance by the Journal is under consideration.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"408"}}